SBHMY (Sino Biopharmaceutical) Days Payable : 113.53 (As of Jun. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Sino Biopharmaceutical Days Payable?

Sino Biopharmaceutical's average Accounts Payable for the six months ended in Jun. 2024 was $244 Mil. Sino Biopharmaceutical's Cost of Goods Sold for the six months ended in Jun. 2024 was $392 Mil. Hence, Sino Biopharmaceutical's Days Payable for the six months ended in Jun. 2024 was 113.53.

The historical rank and industry rank for Sino Biopharmaceutical's Days Payable or its related term are showing as below:

SBHMY' s Days Payable Range Over the Past 10 Years
Min: 78 Med: 115.88 Max: 142.09
Current: 115

During the past 13 years, Sino Biopharmaceutical's highest Days Payable was 142.09. The lowest was 78.00. And the median was 115.88.

SBHMY's Days Payable is ranked worse than
51.21% of 705 companies
in the Biotechnology industry
Industry Median: 122.62 vs SBHMY: 115.00

Sino Biopharmaceutical's Days Payable declined from Jun. 2023 (134.05) to Jun. 2024 (113.53). It may suggest that Sino Biopharmaceutical accelerated paying its suppliers.

Sino Biopharmaceutical Days Payable Historical Data

The historical data trend for Sino Biopharmaceutical's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sino Biopharmaceutical Days Payable Chart

Sino Biopharmaceutical Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Days Payable

Get a 7-Day Free Trial

128.00

122.88

141.96

110.15

97.76

Sino Biopharmaceutical Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Days Payable	Get a 7-Day Free Trial															264.21	134.05	132.31	113.53	135.10

Competitive Comparison of Sino Biopharmaceutical's Days Payable

For the Biotechnology subindustry, Sino Biopharmaceutical's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sino Biopharmaceutical's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sino Biopharmaceutical's Days Payable distribution charts can be found below:

* The bar in red indicates where Sino Biopharmaceutical's Days Payable falls into.

Save Embed

;

Save Embed

;

Sino Biopharmaceutical Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Sino Biopharmaceutical's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (234.857	+	186.928)	/	2 )	/	698.843	*	365
=	210.8925					/	698.843	*	365
=	110.15

Sino Biopharmaceutical's Days Payable for the quarter that ended in Jun. 2024 is calculated as:

	Days Payable (Q: Jun. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Dec. 2023 )	+	Accounts Payable (Q: Jun. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Jun. 2024 )	*	Days in Period
=	( (186.928	+	300.964)	/	2 )	/	392.129	*	365 / 2
=	243.946					/	392.129	*	365 / 2
=	113.53

Sino Biopharmaceutical Days Payable Related Terms

Thank you for viewing the detailed overview of Sino Biopharmaceutical's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Sino Biopharmaceutical Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sino Biopharmaceutical Ltd (OTCPK:SBHMY) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

SBMFF:USA 01177:Hong Kong SMZ1:Germany

Address

1 Harbour Road, Unit 09, 41st Floor, Office Tower, Room 4109, Convention Plaza, Wanchai, Hong Kong, HKG

Website

https://www.sinobiopharm.com

Listed on the Hong Kong Stock Exchange in 2000, Sino Biopharmaceutical is one of the largest Chinese drugmakers. It started with generic drug manufacturing. Since 2018, Sino Biopharm has been actively pivoting into an innovative drugmaker after the Chinese government launched its volume-based procurement policy for the healthcare industry. As of 2024, 41.8% of the firm's total revenue comes from its innovative product category, which includes innovative drugs and biosimilar drugs. Sino Biopharm's biggest revenue segment is oncology medicines, accounting for 37.2% of total revenue, followed by hepatitis, surgery/analgesia, respiratory, and cardio-cerebral vascular therapeutic areas.